Back to Results
First PageMeta Content
Immunotherapy / Cancer organizations / Melanoma / Ipilimumab / Cancer immunotherapy / Management of cancer / University of Texas MD Anderson Cancer Center / James L. Gulley / Cancer vaccine / Medicine / Cancer treatments / Immunology


Collaboration with Johnson & Johnson Innovation announced Tuesday, January 21, 2014 MD Anderson will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech Inc., to develop immunology-based
Add to Reading List

Document Date: 2015-05-09 06:44:39

Open Document

File Size: 37,13 KB

Share Result on Facebook
UPDATE